Name: Marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe – Tendances et prévisions du secteur jusqu'en 2031
Brand: Data Bridge Market Research
SKU: 70321
Price: 2000.00 USD
Availability: InStock
Rating: 4.5 (51 reviews)

Us Japan And Europe Computer Aided Detection Cad Market

Taille du marché en milliards USD

TCAC : 12.00 %

3,609.06 2024 2031

Période de prévision	2025 –2031
Taille du marché (année de référence)	MILLIONS DE DOLLARS AMÉRICAINS Demande
Taille du marché (année de prévision)	Dollars américains 3,609.06
TCAC	12.00 %
Principaux acteurs du marché	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 < /li> Demande de déverrouillage

Marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe, par type de produit (logiciels et services), modalité d'imagerie (imagerie mammaire, imagerie pulmonaire, oncologie et radiothérapie, imagerie abdominale et pelvienne, imagerie dentaire, imagerie cardiovasculaire et autres), application (cancer, troubles neurologiques, maladies cardiovasculaires, maladies musculo-squelettiques et autres), mode d'achat (organisation d'achat groupé et individuel), utilisateur final (hôpitaux, centres de diagnostic, instituts de recherche et centres universitaires, et autres) - Tendances et prévisions de l'industrie jusqu'en 2031.

Analyse et taille du marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe

Le marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe devrait connaître une croissance du marché au cours de la période de prévision de 2024 à 2031.

Data Bridge Market Research analyse que le marché croît avec un TCAC de 12 % au cours de la période de prévision de 2024 à 2031 et devrait atteindre 3 609,06 millions USD d'ici 2031. La demande croissante de systèmes de CAO devrait stimuler l'expansion du marché.

Rapport métrique	Détails
Période de prévision	2024 à 2031
Année de base	2023
Année historique	2022 (Personnalisable 2016-2021)
Unités quantitatives	Chiffre d'affaires en millions USD et prix en USD
Segments couverts	Type de produit (logiciel et services), modalité d'imagerie ( imagerie mammaire , imagerie pulmonaire, oncologie et radiothérapie, imagerie abdominale et pelvienne, imagerie dentaire, imagerie cardiovasculaire et autres), application (cancer, troubles neurologiques, maladies cardiovasculaires, maladies musculo-squelettiques et autres), mode d'achat (organisation d'achat groupé et individuel), utilisateur final (hôpitaux, centres de diagnostic, instituts de recherche et centres universitaires et autres)
Pays couverts	États-Unis, Japon, Allemagne, Italie, Royaume-Uni, France, Suisse, Espagne, Russie, Turquie, Belgique, Pays-Bas et reste de l'Europe
Acteurs du marché couverts	CANON MEDICAL SYATEMA CORPORATION, Riverain Technologies, Koninklijke Philips NV, Seimens Healthineers AG, Hologic Inc., FUJIFILM Holdings Corporation, Median Technologies, General Electric Company, iCAD, and Inc., EDDA Technology, Inc. entre autres

Définition du marché

Le terme « détection assistée par ordinateur » (DAO) décrit le processus d'interprétation des examens d'imagerie médicale, tels que les radiographies, les tomodensitogrammes et les IRM, à l'aide d'algorithmes et de logiciels informatiques. Les zones d'intérêt ou les anomalies possibles dans les images sont mises en évidence et signalées par les systèmes de DAO afin qu'un radiologue ou un autre professionnel de la santé puisse les examiner plus en détail. Ces systèmes analysent les motifs, les formes et les densités dans les images pour augmenter l'efficacité et la précision du diagnostic en mettant en évidence les zones qui pourraient nécessiter un examen plus approfondi. La DAO est un outil utile dans le processus de diagnostic qui aide les professionnels de la santé à comprendre et à prendre des décisions, même si elle ne peut pas remplacer les compétences humaines.

Dynamique du marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe

Cette section traite de la compréhension des moteurs, des avantages, des opportunités, des contraintes et des défis du marché. Tout cela est discuté en détail ci-dessous :

Conducteurs

Application croissante du système de détection assistée par ordinateur (CAO) dans le domaine médical

Le marché des systèmes de détection assistée par ordinateur (DAO) est en pleine croissance et en pleine évolution en raison de la mise en œuvre croissante de ces systèmes dans diverses disciplines médicales. Les systèmes de DAO ont été largement utilisés en radiologie pour identifier les complexités des images, telles que les mammographies, mais ils se sont rapidement répandus dans de nombreuses autres spécialités médicales. L'utilisation croissante des systèmes de DAO dans des domaines de spécialité autres que la radiologie (pathologie, cardiologie, oncologie et neurologie) indique leur adaptabilité et leur efficacité pour aider le personnel médical dans diverses disciplines. Les procédures de soins de santé sont révolutionnées par la capacité de la DAO à fournir une identification précoce, un diagnostic précis et une planification du traitement pour une variété de maladies.

L'adoption et l'utilisation croissantes des systèmes de CAO dans un certain nombre de spécialités médicales mettent en évidence leur influence révolutionnaire sur la prestation des soins de santé. L'utilisation de ces systèmes dans diverses spécialisations est en augmentation car ils se révèlent prometteurs pour faciliter des diagnostics plus précoces et plus précis, améliorer les résultats des traitements et améliorer les soins aux patients. Ainsi, l'application croissante des systèmes de CAO dans le domaine médical stimule la croissance du marché.

Progrès technologiques croissants associés à la CAO

Le principal facteur à l’origine de la croissance et de l’expansion du marché de la détection assistée par ordinateur (DAO) dans le secteur de la santé est l’amélioration technologique. Ces développements permettent de maintenir les systèmes de DAO à jour et d’améliorer leur adaptabilité, leur précision et leur capacité à diagnostiquer un large éventail de troubles médicaux. Le développement d’algorithmes d’apprentissage profond, d’apprentissage automatique et d’intelligence artificielle (IA) a été essentiel à l’avancement des systèmes de DAO. Ces développements permettent aux logiciels de DAO de traiter d’énormes volumes de données d’imagerie médicale à des vitesses et une précision jusqu’alors inédites. Cela se traduit par une identification plus précise et plus fiable des anomalies dans les IRM, les tomodensitogrammes, les rayons X et d’autres modalités d’imagerie.

Les systèmes de CAO progresseront en matière de détection, d'adaptabilité et d'intégration aux écosystèmes de soins de santé à mesure que les progrès technologiques se poursuivront. Le marché se développe grâce à l'application inébranlable des améliorations technologiques par l'industrie de la CAO, qui ont l'énorme potentiel de révolutionner les soins aux patients, d'améliorer les capacités de diagnostic et d'influencer l'orientation des soins de santé. Ainsi, les avancées technologiques croissantes stimulent la croissance du marché.

Opportunités

Infrastructures de santé avancées des pays

L'infrastructure de santé avancée aux États-Unis, au Japon et en Europe est un facteur de création d'opportunités significatives sur le marché. Aux États-Unis, le réseau bien établi d'hôpitaux et de centres de diagnostic, associé à des installations médicales sophistiquées, offre un terrain fertile pour l'intégration transparente des technologies de CAO. La robuste infrastructure accélère l'adoption des systèmes de CAO, améliorant l'efficacité et la précision de l'imagerie et du diagnostic médicaux.

Dans les trois régions, l’infrastructure de pointe des soins de santé pose non seulement les bases de la mise en œuvre de la CAO, mais reflète également un engagement à tirer parti des technologies de pointe pour améliorer les soins aux patients. Cet engagement, combiné à la préparation technologique des systèmes de santé, crée un environnement dans lequel la CAO peut prospérer, offrant des capacités de diagnostic avancées qui contribuent à des interventions médicales plus précises et plus rapides, ce qui devrait créer des opportunités de croissance du marché.

Restrictions/Défi

Coût élevé des systèmes de détection assistée par ordinateur (CAO)

De nombreux établissements de santé ont du mal à intégrer les systèmes de CAO dans leurs flux de travail de diagnostic en raison de l'investissement initial nécessaire à l'acquisition et à la mise en œuvre du système de CAO. Du matériel et des logiciels spécifiques à l'imagerie médicale sont souvent nécessaires pour les systèmes de CAO. Ces systèmes peuvent entraîner des coûts initiaux élevés, en particulier pour les établissements de santé de petite taille ou ceux dont les budgets sont plus serrés.

Le coût total de possession comprend des dépenses supplémentaires pour la maintenance continue, les mises à jour et les licences après la dépense initiale. Le coût est augmenté par la nécessité de s'assurer que le système est à jour avec les nouveaux développements et conforme aux exigences légales. Il faut plus de temps et de ressources pour former les professionnels de la santé à utiliser efficacement les systèmes de CAO et à les intégrer de manière transparente dans les opérations actuelles. Des dépenses sont associées à cette formation, tant pour le déploiement initial que pour la formation continue à mesure que de nouvelles fonctionnalités ou mises à jour sont publiées.

Les prestataires de soins de santé, en particulier les petits cabinets ou les institutions disposant de fonds limités, sont réticents à utiliser les systèmes de CAO en raison de leur coût élevé. L'accès des patients aux avantages des diagnostics plus précis et plus efficaces des systèmes de CAO est limité par cet obstacle à l'adoption. Les ressources financières des établissements de santé, en particulier des petits cabinets ou de ceux qui ont de faibles ressources, sont mises à rude épreuve par l'effet cumulatif des dépenses de maintenance. Ainsi, le coût élevé des systèmes de détection assistée par ordinateur (CAO) freine la croissance du marché.

Portée du marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe

Le marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe est segmenté en cinq segments notables en fonction du type de produit, de la modalité d'imagerie, du mode d'achat et de l'utilisateur final.

Type de produit

Logiciel
Services

Sur la base du type de produit, le marché est segmenté en logiciels et services.

Modalité d'imagerie

Imagerie mammaire
Imagerie pulmonaire
Oncologie et radiothérapie
Imagerie abdominale et pelvienne
Imagerie dentaire
Imagerie cardiovasculaire
Autres

Sur la base de la modalité d'imagerie, le marché est segmenté en imagerie mammaire, imagerie pulmonaire, oncologie et radiothérapie, imagerie abdominale et pelvienne, imagerie dentaire, imagerie cardiovasculaire et autres.

Application

Cancer
Troubles neurologiques
Maladies cardiovasculaires
Maladies musculo-squelettiques
Autres

Sur la base des applications, le marché est segmenté en cancer, troubles neurologiques, maladies cardiovasculaires, maladies musculo-squelettiques et autres.

Mode d'achat

Organisation d'achat groupé
Individuel

Sur la base du mode d’achat, le marché est segmenté en organisation d’achat groupé et en organisation d’achat individuelle.

Utilisateur final

Hôpitaux
Centres de diagnostic
Instituts de recherche et centres universitaires
Autres

Sur la base de l’utilisateur final, le marché est segmenté en hôpitaux, centres de diagnostic, instituts de recherche et centres universitaires, et autres.

Analyse/perspectives régionales du marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe

Le marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe est analysé, et des informations et tendances sur la taille du marché sont fournies en fonction du type de produit, de la modalité d'imagerie, de l'application, du mode d'achat et de l'utilisateur final.

Les pays couverts dans le rapport sur le marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe sont les États-Unis, l'Allemagne, l'Italie, le Royaume-Uni, la France, la Suisse, l'Espagne, la Russie, la Turquie, la Belgique, les Pays-Bas et le reste de l'Europe.

Les États-Unis devraient dominer le marché nord-américain, car ils sont l'un des plus grands producteurs mondiaux de systèmes de CAO. Le Japon devrait dominer le marché de la région Asie-Pacifique, car il possède une longue histoire dans le domaine des technologies médicales. L'Allemagne devrait dominer le marché, car les professionnels de la santé allemands utilisent souvent des pratiques de CAO modernes et efficaces, ce qui peut conduire à des ventes plus élevées et à une CAO de meilleure qualité.

La section pays du rapport fournit également des facteurs individuels ayant un impact sur le marché et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces du porteur, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Analyse du paysage concurrentiel et des parts de marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe

Le paysage concurrentiel du marché américain, japonais et européen de la détection assistée par ordinateur (CAO) fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises sur le marché américain, japonais et européen de la détection assistée par ordinateur (CAO).

Certains des principaux acteurs opérant sur le marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe sont CANON MEDICAL SYATEMA CORPORATION, Riverain Technologies, Koninklijke Philips NV, Seimens Healthineers AG, Hologic Inc., FUJIFILM Holdings Corporation, Median Technologies, General Electric Company, iCAD, and Inc., EDDA Technology, Inc.

SKU-70321

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Cliquez sur l'image pour l'agrandir

Tableau de bord d'analyse de données interactif
Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
Accès d'analyste de recherche pour la personnalisation et les requêtes
Analyse de la concurrence avec tableau de bord interactif
Dernières actualités, mises à jour et analyse des tendances
Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence

Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 DBMR MARKET POSITION GRID

2.7 MULTIVARIATE MODELLING

2.8 TYPE LIFELINE CURVE

2.9 MARKET END USER COVERAGE GRID

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL

4.2 PORTERS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISING APPLICATION OF COMPUTER-AIDED DETECTION (CAD) SYSTEM IN MEDICAL FIELD

5.1.2 INCREASING TECHNOLOGICAL ADVANCEMENTS ASSOCIATED WITH CAD

5.1.3 GOVERNMENT INITIATIVES FOR COMPUTER AIDED DETECTION (CAD) SYSTEMS

5.2 RESTRAINTS

5.2.1 HIGH COST OF COMPUTER AIDED DETECTION (CAD) SYSTEMS

5.2.2 STRICT GUIDELINES FOR COMPUTER AIDED DETECTION (CAD)

5.3 OPPORTUNITIES

5.3.1 ADVANCED HEALTHCARE INFRASTRUCTURE OF THE COUNTRIES

5.3.2 INCREASING AWARENESS REGARDING ACCURATE DIAGNOSIS

5.4 CHALLENGE

5.4.1 DEPENDENCY ON SKILLED MEDICAL PROFESSIONALS

6 US, JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 SOFTWARE

6.2.1 INTEGRATED CAD SYSTEMS

6.2.1.1 CLOUD BASED

6.2.1.2 ON PREMISES

6.2.2 STANDALONE CAD SYSTEMS

6.2.2.1 CLOUD BASED

6.2.2.2 ON PREMISES

6.3 SERVICES

7 US, JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY

7.1 OVERVIEW

7.2 ONCOLOGY AND RADIATION

7.2.1 BY TYPE

7.2.1.1 ONCOLOGY CAD

7.2.1.2 RADIATION THERAPY PLANNING

7.2.2 BY TUMOR TYPE

7.2.2.1 MALIGNANT

7.2.2.2 BENIGN

7.2.3 BY PRODUCT TYPE

7.2.3.1 SOFTWARE

7.2.3.2 SERVICES

7.3 BREAST IMAGING

7.3.1 BY TYPE

7.3.1.1 MAMMOGRAPHY CAD

7.3.1.2 BREAST ULTRASOUND CAD

7.3.2 BY PRODUCT TYPE

7.3.2.1 SOFTWARE

7.3.2.2 SERVICES

7.4 LUNG IMAGING

7.4.1 BY TYPE

7.4.1.1 CHEST X-RAY CAD

7.4.1.2 CHEST CT CAD ON PULMONARY NODULES

7.4.2 BY NODULE SIZE

7.4.2.1 >4MM AND <5MM

7.4.2.2 >5MM

7.4.2.3 3 MM AND < 4MM

7.4.3 BY NODULE

7.4.3.1 PART SOLID NODULES

7.4.3.2 NON- SOLID NODULES

7.4.4 BY NODULE TYPE

7.4.4.1 JUXTAPLEURAL NODULES

7.4.4.2 ISOLATED NODULES

7.4.4.3 GROUND-GLASS NODULES

7.4.5 BY PRODUCT TYPE

7.4.5.1 SOFTWARE

7.4.5.2 SERVICES

7.5 CARDIOVASCULAR IMAGING

7.5.1 BY TYPE

7.5.1.1 CARDIAC CT CAD

7.5.1.2 CARDIAC MT CAD

7.5.2 BY PRODUCT TYPE

7.5.2.1 SOFTWARE

7.5.2.2 SERVICES

7.6 ABDOMINAL AND PELVIC IMAGING

7.6.1 BY TYPE

7.6.1.1 GASTROINTESTINAL CAD

7.6.1.2 ABDOMINAL CT CAD

7.6.1.3 KIDNEY CAD

7.6.2 BY PRODUCT TYPE

7.6.2.1 SOFTWARE

7.6.2.2 SERVICES

7.7 DENTAL IMAGING

7.7.1 BY PRODUCT TYPE

7.7.1.1 SOFTWARE

7.7.1.2 SERVICES

7.8 OTHERS

8 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 CANCER

8.2.1 BY TYPE

8.2.1.1 BREAST CANCER

8.2.1.2 COLORECTAL CANCER

8.2.1.3 LUNG CANCER

8.2.1.4 PROSTATE CANCER

8.2.1.5 LIVER CANCER

8.2.1.6 BONE CANCER

8.2.1.7 OTHERS

8.2.2 BY PRODUCT TYPE

8.2.2.1 SOFTWARE

8.2.2.2 SERVICES

8.3 NEUROLOGICAL DISORDERS

8.3.1 BY TYPE

8.3.1.1 MULTIPLE SCLEROSIS

8.3.1.2 STROKE

8.3.1.3 OTHERS

8.3.2 BY PRODUCT TYPE

8.3.2.1 SOFTWARE

8.3.2.2 SERVICES

8.4 CARDIOVASCULAR DISEASES

8.4.1 BY TYPE

8.4.1.1 CORONARY ARTERY DISEASE

8.4.1.2 CONGENITAL HEART DEFECTS

8.4.1.3 VALVULAR HEART DISEASE

8.4.1.4 OTHERS

8.4.2 BY PRODUCT TYPE

8.4.2.1 SOFTWARE

8.4.2.2 SERVICES

8.5 MUSCULOSKELETAL DISEASES

8.5.1 BY TYPE

8.5.1.1 OSTEOARTHRITIS

8.5.1.2 RHEUMATOID ARTHRITIS

8.5.1.3 JOINT DISORDERS

8.5.1.4 OTHERS

8.6 OTHERS

9 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE

9.1 OVERVIEW

9.2 GROUP PURCHASE ORGANIZATIONS

9.3 INDIVIDUAL

10 US, JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.2.1 PRIVATE

10.2.2 PUBLIC

10.3 DIAGNOSTIC CENTERS

10.4 RESEARCH CENTERS & ACADEMIC INSTITUTES

10.5 OTHERS

11 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET BY REGION

11.1 EUROPE

11.1.1 GERMANY

11.1.2 FRANCE

11.1.3 U.K.

11.1.4 SPAIN

11.1.5 ITALY

11.1.6 NETHERLANDS

11.1.7 BELGIUM

11.1.8 SWITZERLAND

11.1.9 RUSSIA

11.1.10 TURKEY

11.1.11 REST OF EUROPE

12 COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: U.S., JAPAN & EUROPE

12.2 COMPANY SHARE ANALYSIS: U.S.

12.3 COMPANY SHARE ANALYSIS: JAPAN

12.4 COMPANY SHARE ANALYSIS: EUROPE

13 SWOT ANALYSIS

14 COMPANY PROFILES

14.1 KONINKLIJKE PHILIPS N.V.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 PRODUCT PORTFOLIO

14.1.4 RECENT DEVELOPMENT

14.2 FUJIFILM HOLDINGS CORPORATION

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 PRODUCT PORTFOLIO

14.2.4 RECENT DEVELOPMENT

14.3 CANON MEDICAL SYSTEMS CORPORATION

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 PRODUCT PORTFOLIO

14.3.4 RECENT DEVELOPMENT

14.4 SIEMENS HEALTHINEERS AG

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENT

14.5 MEDIAN TECHNOLOGIES.

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 PRODUCT PORTFOLIO

14.5.4 RECENT DEVELOPMENT

14.6 EDDA TECHNOLOGY, INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENT

14.7 GENERAL ELECTRIC

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 HOLOGIC INC.

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENT

14.9 ICAD, INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT DEVELOPMENT

14.1 RIVERAIN TECHNOLOGIES

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

Liste des tableaux

TABLE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2023- 2031 (USD MILLION)

TABLE 2 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2023-2031 (USD MILLION)

TABLE 3 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2023-2031 (USD MILLION)

TABLE 4 U.S. SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 5 JAPAN SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 6 EUROPE SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 7 U.S. INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 8 JAPAN INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 9 EUROPE INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 10 U.S. STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 11 JAPAN STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 12 EUROPE STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 13 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2023- 2031 (USD MILLION)

TABLE 14 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2023-2031 (USD MILLION)

TABLE 15 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2023-2031 (USD MILLION)

TABLE 16 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 17 JAPAN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 18 EUROPE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)

TABLE 19 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 20 JAPAN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 21 EUROPE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2021-2031 (USD MILLION)

TABLE 22 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 23 JAPAN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 24 EUROPE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2021-2031 (USD MILLION)

TABLE 25 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 26 JAPAN BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 27 EUROPE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)

TABLE 28 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 29 JAPAN BRESAT IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 30 EUROPE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)

TABLE 31 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 32 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 33 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)

TABLE 34 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 35 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 36 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2021-2031 (USD MILLION)

TABLE 37 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 38 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE , 2022-2031 (USD MILLION)

TABLE 39 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2021-2031 (USD MILLION)

TABLE 40 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 41 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 42 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2021-2031 (USD MILLION)

TABLE 43 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 44 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 45 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)

TABLE 46 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 47 JAPAN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 48 EUROPE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)

TABLE 49 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 50 JAPAN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 51 EUROPE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)

TABLE 52 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 53 JAPAN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 54 EUROPE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)

TABLE 55 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 56 JAPAN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 57 EUROPE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)

TABLE 58 U.S. DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 59 JAPAN DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 60 EUROPE DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)

TABLE 61 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2023- 2031 (U.S.D MILLION)

TABLE 62 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2023-2031 (U.S.D MILLION)

TABLE 63 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2023-2031 (U.S.D MILLION)

TABLE 64 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)

TABLE 65 JAPAN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)

TABLE 66 EUROPE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)

TABLE 67 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 68 JAPAN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 69 EUROPE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 70 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)

TABLE 71 JAPAN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)

TABLE 72 EUROPE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)

TABLE 73 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 74 JAPAN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 75 EUROPE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 76 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)

TABLE 77 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 78 JAPAN CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 79 EUROPE CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 80 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)

TABLE 81 JAPAN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)

TABLE 82 EUROPE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)

TABLE 83 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 84 JAPAN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 85 EUROPE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)

TABLE 86 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2023- 2031 (USD MILLION)

TABLE 87 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2023-2031 (USD MILLION)

TABLE 88 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2023-2031 (USD MILLION)

TABLE 89 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 90 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 91 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 92 U.S. HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 93 JAPAN HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 94 EUROPE HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 95 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 96 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 97 GERMANY SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 98 GERMANY INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 99 GERMANY STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 100 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)

TABLE 101 GERMANY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 102 GERMANY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 103 GERMANY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 104 GERMANY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 105 GERMANY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 106 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 107 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 108 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 109 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 110 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 111 GERMANY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 112 GERMANY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 113 GERMANY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 114 GERMANY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 115 GERMANY DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 116 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 117 GERMANY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 118 GERMANY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 119 GERMANY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 120 GERMANY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 121 GERMANY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 122 GERMANY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 123 GERMANY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 124 GERMANY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 125 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 126 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 127 GERMANY HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 128 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 129 FRANCE SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 130 FRANCE INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 131 FRANCE STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 132 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)

TABLE 133 FRANCE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 134 FRANCE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 135 FRANCE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 136 FRANCE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 137 FRANCE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 138 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 139 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 140 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 141 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 142 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 143 FRANCE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 144 FRANCE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 145 FRANCE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 146 FRANCE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 147 FRANCE DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 148 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 149 FRANCE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 150 FRANCE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 151 FRANCE CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 152 FRANCE CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 153 FRANCE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 154 FRANCE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 155 FRANCE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 156 FRANCE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 157 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 158 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 159 FRANCE HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 160 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 161 U.K. SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 162 U.K. INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 163 U.K. STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 164 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)

TABLE 165 U.K. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 166 U.K. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 167 U.K. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 168 U.K. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 169 U.K. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 170 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 171 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 172 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 173 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 174 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 175 U.K. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 176 U.K. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 177 U.K. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 178 U.K. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 179 U.K. DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 180 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 181 U.K. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 182 U.K. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 183 U.K. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 184 U.K. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 185 U.K. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 186 U.K. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 187 U.K. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 188 U.K. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 189 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 190 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 191 U.K. HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 192 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 193 SPAIN SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 194 SPAIN INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 195 SPAIN STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 196 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)

TABLE 197 SPAIN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 198 SPAIN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 199 SPAIN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 200 SPAIN BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 201 SPAIN BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 202 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 203 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 204 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 205 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 206 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 207 SPAIN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 208 SPAIN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 209 SPAIN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 210 SPAIN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 211 SPAIN DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 212 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 213 SPAIN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 214 SPAIN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 215 SPAIN CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 216 SPAIN CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 217 SPAIN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 218 SPAIN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 219 SPAIN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 220 SPAIN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 221 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 222 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 223 SPAIN HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 224 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 225 ITALY SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 226 ITALY INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 227 ITALY STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 228 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)

TABLE 229 ITALY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 230 ITALY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 231 ITALY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 232 ITALY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 233 ITALY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 234 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 235 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 236 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 237 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 238 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 239 ITALY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 240 ITALY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 241 ITALY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 242 ITALY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 243 ITALY DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 244 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 245 ITALY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 246 ITALY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 247 ITALY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 248 ITALY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 249 ITALY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 250 ITALY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 251 ITALY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 252 ITALY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 253 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 254 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 255 ITALY HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 256 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 257 NETHERLANDS SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 258 NETHERLANDS INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 259 NETHERLANDS STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 260 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)

TABLE 261 NETHERLANDS ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 262 NETHERLANDS ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 263 NETHERLANDS ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 264 NETHERLANDS BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 265 NETHERLANDS BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 266 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 267 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 268 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 269 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 270 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 271 NETHERLANDS CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 272 NETHERLANDS CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 273 NETHERLANDS ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 274 NETHERLANDS ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 275 NETHERLANDS DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 276 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 277 NETHERLANDS CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 278 NETHERLANDS CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 279 NETHERLANDS CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 280 NETHERLANDS CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 281 NETHERLANDS MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 282 NETHERLANDS MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 283 NETHERLANDS NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 284 NETHERLANDS NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 285 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 286 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 287 NETHERLANDS HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 288 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 289 BELGIUM SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 290 BELGIUM INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 291 BELGIUM STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 292 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)

TABLE 293 BELGIUM ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 294 BELGIUM ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 295 BELGIUM ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 296 BELGIUM BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 297 BELGIUM BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 298 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 299 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 300 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 301 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 302 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 303 BELGIUM CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 304 BELGIUM CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 305 BELGIUM ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 306 BELGIUM ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 307 BELGIUM DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 308 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 309 BELGIUM CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 310 BELGIUM CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 311 BELGIUM CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 312 BELGIUM CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 313 BELGIUM MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 314 BELGIUM MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 315 BELGIUM NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 316 BELGIUM NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 317 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 318 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 319 BELGIUM HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 320 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 321 SWITZERLAND SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 322 SWITZERLAND INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 323 SWITZERLAND STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 324 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)

TABLE 325 SWITZERLAND ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 326 SWITZERLAND ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 327 SWITZERLAND ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 328 SWITZERLAND BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 329 SWITZERLAND BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 330 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 331 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 332 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 333 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 334 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 335 SWITZERLAND CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 336 SWITZERLAND CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 337 SWITZERLAND ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 338 SWITZERLAND ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 339 SWITZERLAND DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 340 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 341 SWITZERLAND CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 342 SWITZERLAND CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 343 SWITZERLAND CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 344 SWITZERLAND CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 345 SWITZERLAND MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 346 SWITZERLAND MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 347 SWITZERLAND NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 348 SWITZERLAND NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 349 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 350 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 351 SWITZERLAND HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 352 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 353 RUSSIA SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 354 RUSSIA INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 355 RUSSIA STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 356 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)

TABLE 357 RUSSIA ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 358 RUSSIA ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 359 RUSSIA ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 360 RUSSIA BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 361 RUSSIA BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 362 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 363 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 364 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 365 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 366 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 367 RUSSIA CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 368 RUSSIA CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 369 RUSSIA ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 370 RUSSIA ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 371 RUSSIA DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 372 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 373 RUSSIA CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 374 RUSSIA CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 375 RUSSIA CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 376 RUSSIA CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 377 RUSSIA MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 378 RUSSIA MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 379 RUSSIA NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 380 RUSSIA NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 381 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 382 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 383 RUSSIA HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 384 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 385 TURKEY SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 386 TURKEY INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 387 TURKEY STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 388 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)

TABLE 389 TURKEY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 390 TURKEY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 391 TURKEY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 392 TURKEY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 393 TURKEY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 394 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 395 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 396 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 397 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 398 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 399 TURKEY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 400 TURKEY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 401 TURKEY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 402 TURKEY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 403 TURKEY DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 404 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 405 TURKEY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 406 TURKEY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 407 TURKEY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 408 TURKEY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 409 TURKEY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 410 TURKEY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 411 TURKEY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 412 TURKEY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 413 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 414 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 415 TURKEY HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 416 REST OF EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

Liste des figures

FIGURE 1 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION

FIGURE 2 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: DATA TRIANGULATION

FIGURE 3 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: DROC ANALYSIS

FIGURE 4 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: REGIONAL AND COUNTRY LEVEL MARKET ANALYSIS

FIGURE 5 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: COUNTRY LEVEL MARKET ANALYSIS

FIGURE 6 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: REGIONAL AND COUNTRY LEVEL MARKET ANALYSIS

FIGURE 7 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 8 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 9 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: DBMR MARKET POSITION GRID

FIGURE 10 JAPAN LIFELINE CURVE

FIGURE 11 EUROPE LIFELINE CURVE

FIGURE 12 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: MARKET END USER COVERAGE GRID

FIGURE 13 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION

FIGURE 14 INCREASING TECHNOLOGICAL ADVANCEMENTS IS DRIVING THE GROWTH OF U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN THE FORECAST PERIOD OF 2024 TO 2031

FIGURE 15 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031

FIGURE 16 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031

FIGURE 17 SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031

FIGURE 18 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031

FIGURE 19 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031

FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET

FIGURE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023

FIGURE 22 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023

FIGURE 23 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023

FIGURE 24 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)

FIGURE 25 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)

FIGURE 26 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)

FIGURE 27 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, CAGR (2024-2031)

FIGURE 28 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE CAGR (2024-2031)

FIGURE 29 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, CAGR (2024-2031)

FIGURE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 31 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 32 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 33 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2023

FIGURE 34 JAPAN ORTHOTIC DEVICES MARKET: BY IMAGING MODALITY, 2023

FIGURE 35 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2023

FIGURE 36 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)

FIGURE 37 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)

FIGURE 38 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)

FIGURE 39 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, CAGR (2024-2031)

FIGURE 40 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY CAGR (2024-2031)

FIGURE 41 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, CAGR (2024-2031)

FIGURE 42 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE

FIGURE 43 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE

FIGURE 44 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE

FIGURE 45 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023

FIGURE 46 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023

FIGURE 47 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023

FIGURE 48 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (U.S.D MILLION)

FIGURE 49 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (U.S.D MILLION)

FIGURE 50 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (U.S.D MILLION)

FIGURE 51 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 52 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION CAGR (2024-2031)

FIGURE 53 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 54 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 55 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 56 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 57 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023

FIGURE 58 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023

FIGURE 59 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023

FIGURE 60 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)

FIGURE 61 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)

FIGURE 62 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)

FIGURE 63 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)

FIGURE 64 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE CAGR (2024-2031)

FIGURE 65 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)

FIGURE 66 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE

FIGURE 67 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE

FIGURE 68 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE

FIGURE 69 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023

FIGURE 70 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023

FIGURE 71 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023

FIGURE 72 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 73 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 74 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 75 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)

FIGURE 76 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)

FIGURE 77 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)

FIGURE 78 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE

FIGURE 79 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE

FIGURE 80 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE

FIGURE 81 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: SNAPSHOT (2023)

FIGURE 82 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)

FIGURE 83 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)

FIGURE 84 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)

FIGURE 85 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)

Voir les informations détaillées

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.